US FDA Allows More Time to Comment on Proposed Rule for Combo Products

International Medical Device Regulatory Monitor
A A
At the request of stakeholders, the U.S. Food and Drug Administration (FDA) has extended the comment period to Feb. 5 on a proposed rule on good manufacturing practices (GMPs) for combination products.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $20.00